BCL2 and melanoma: Bcl-2 itself is highly expressed in the majority of cases of acute leukaemia, approximately 50% of diffuse large B-cell lymphomas and up to 90% of malignant melanomas (Banker et al, 1997; Jansen et al, 1998; Campos et al, 1999; Skinnider et al, 1999).